In view of the Agency's double role, a part, though a relatively small one, of its budget must to be covered by the European Union and another part by fees for services rendered to pharmaceutical companies.
In view of the Agency's double role, a part, though a relatively small one, of its budget must to be covered by the European Union and another part by fees for services rendered to pharmaceutical companies.